Managed Account Advisors’s Novartis NVS Stock Holding History

Managed Account Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$380M	Sell	4,306,750 -46,485	-1%	-$4.26M	0.31%	86
2015 Q1	$385M	Sell	4,353,235 -81,174	-2%	-$7.2M	0.34%	74
2014 Q4	$368M	Sell	4,434,409 -75,146	-2%	-$6.23M	0.36%	64
2014 Q3	$380M	Buy	4,509,555 +89,891	+2%	+$7.27M	0.42%	45
2014 Q2	$359M	Buy	4,419,664 +254,277	+6%	+$20M	0.43%	39
2014 Q1	$317M	Buy	4,165,387 +55,488	+1%	+$4.04M	0.41%	43
2013 Q4	$296M	Sell	4,109,899 -25,186	-0.6%	-$1.75M	0.4%	47
2013 Q3	$284M	Buy	4,135,085 +125,824	+3%	+$8.32M	0.42%	43
2013 Q2	$254M	Buy	+4,009,261	New	+$261M	0.39%	44

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Managed Account Advisors's NVS Position: Q2 2015 in Review

Managed Account Advisors reduced its Novartis (NVS) stake by 1.1% in Q2 2015, selling an estimated $4.26M and leaving 4,306,750 shares worth $380M. The position accounts for 0.31% of the portfolio, ranked #86.

Managed Account Advisors first reported a position in NVS in Q2 2013 and has held it in 9 quarters since. The position peaked at $385M in Q1 2015. 945 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

Managed Account Advisors held 4,306,750 shares of Novartis worth $380M as of Q2 2015.
Managed Account Advisors sold 46,485 Novartis shares in Q2 2015, an estimated $4.26M.
Novartis made up 0.31% of Managed Account Advisors's portfolio in Q2 2015, its #86 holding.
Managed Account Advisors first reported a position in Novartis in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Novartis position peaked at $385M in Q1 2015.
945 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.